Home » Topics » BioWorld

BioWorld
RSS

CELLPRO SYSTEM IN NEW GENE THERAPY TRIAL

March 16, 1992

FDA MOVES QUICKLY ON HEPATITIS C TESTS

March 16, 1992

LIPO NETS $38.6 MILLION IN STOCK SALE

March 16, 1992

CELLCOR IPO RAISES $22 MILLION

March 16, 1992

NIH PATENT CLAIMS MANY VARIATIONS

March 13, 1992

ANOTHER ALZHEIMER'S MODEL RETRACTED

March 13, 1992

FDA PANEL VOTES FOR CHIRON BLOOD TEST

March 13, 1992

SYNTHECELL TO ACQUIRE VEGA BIOTECH

March 13, 1992

METRA BOOSTS SECOND-ROUND STAKE

March 13, 1992

THERATECH FILES FOR IPO

March 12, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...